북미의 독성학 연구소 시장 : 북미의 업계 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2030년) - 약제 클래스별, 제품 유형별, 샘플별, 국가별, 기업별

The North America toxicology laboratories market, unveiling promising forecasts and insightful trends driving the industry's evolution. With an impeccable Compound Annual Growth Rate (CAGR) of 10.4% projected during the forecast period, the market is expected to surge from US$255.2 million in 2023 to an estimated US$511.2 million by the end of 2030.

Rapid Screening Technologies: A Key Driver of Growth

The report highlights the increasing significance of rapid screening technologies as a primary trend propelling market expansion. With advancements in technologies such as Gas Chromatography-Mass Spectrometry (GC-MS), toxicology laboratories are witnessing a surge in demand for efficient screening methods, enhancing turnaround times and sensitivity.

Integration of Informatics and Data Solutions

Another pivotal trend identified in the report is the integration of informatics and data solutions within toxicology laboratories. Confidential test results are securely stored in mass spectral databases, emphasizing the importance of data integrity and confidentiality in the industry.

Key Segment Insights

• Drug Class Dominance: Amphetamines emerge as the leading segment, capturing 17.9% of the market share and projected to grow at a robust CAGR of 11.0% during the forecast period.
• Product Type Leadership: Reagent and kits claim the majority share of 61.6%, expected to grow at a steady CAGR of 9.7% over the forecast period.

Regulatory Frameworks Fueling Market Growth

The report underscores the role of robust regulatory frameworks in driving market growth across industries such as pharmaceuticals, cosmetics, food, and chemicals. Stricter regulations in the US and Canada mandate rigorous testing, creating a conducive environment for market expansion.

Challenges and Opportunities

While traditional toxicology laboratories face challenges from the introduction of point-of-care testing devices, increasing government spending on toxicity testing presents lucrative opportunities for market players. Collaborations between regulatory bodies and industry stakeholders further stimulate innovation and growth.

Competitive Analysis

Prominent organizations are spearheading the sector with innovative solutions and strategic alliances. Competitive intelligence and strategic decision-making remain crucial for companies navigating the dynamic landscape of the toxicology laboratories market.

Global North America Toxicology Laboratories Market:

• Thermo Fisher Scientific, Inc.
• Bio Rad Laboratories Inc.
• Neogen Corporation
• Danaher Corporation
• Agilent
• Redwood Toxicology Laboratory
• Abbott (Alere, Inc.)

Global North America Toxicology Laboratories Market Is Segmented as Below:

Drug Class:

• Alcohol
• Amphetamines
• Barbiturates
• Benzodiazepines
• Illicit Drugs
• Opiates/Opioids
• Tricyclic's Antidepressants
• Z Drugs
• Misc

Product Type:

• Reagent Kits
  • ELISA
  • PCR
  • Enzyme Multiplied Immunoassay Technique (EMIT)
  • Radio Immuno-sorbent Assay (RIA)
• Instruments
  • Immunochemistry Analyzers
  • PCR Machine
  • Gas Chromatography/Mass Spectrometry (GS/MS)
  • High Performance Liquid Chromatography (HPLC)

Sample:

• Urine
• Blood
• Hair
• Oral Fluid

End User:

• Hospitals
• Clinics
• Diagnostic Laboratories
• Forensic Laboratories
• Rehabilitation Centers

By Geographic Coverage:

• North America
  • U.S.
  • Canada

Table of Contents

1. Executive Summary

• 1.1. North America Toxicology Laboratories Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2022
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. Covid-19 Impact Analysis
  • 2.5.1. Overview
  • 2.5.2. Impact By Region
• 2.6. Economic Overview
  • 2.6.1. World Economic Projections
• 2.7. PESTLE Analysis

3. North America Toxicology Laboratories Market Outlook, 2018 - 2030

• 3.1. North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2030
  • 3.1.1. Key Highlights
    • 3.1.1.1. Alcohol
    • 3.1.1.2. Amphetamines
    • 3.1.1.3. Barbiturates
    • 3.1.1.4. Benzodiazepines
    • 3.1.1.5. Illicit Drugs
    • 3.1.1.6. Opiates/Opioids
    • 3.1.1.7. Tricyclic's Antidepressants
    • 3.1.1.8. Z Drugs
    • 3.1.1.9. Others
• 3.2. North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030
  • 3.2.1. Key Highlights
    • 3.2.1.1. Reagent Kits
      • 3.2.1.1.1. ELISA
      • 3.2.1.1.2. PCR
      • 3.2.1.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 3.2.1.1.4. Radio Immuno-sorbent Assay (RIA)
    • 3.2.1.2. Instruments
      • 3.2.1.2.1. Immunochemistry Analyzers
      • 3.2.1.2.2. PCR Machine
      • 3.2.1.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 3.2.1.2.4. High Performance Liquid Chromatography (HPLC)
• 3.3. North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2018 - 2030
  • 3.3.1. Key Highlights
    • 3.3.1.1. Urine
    • 3.3.1.2. Blood
    • 3.3.1.3. Hair
    • 3.3.1.4. Oral Fluid
  • 3.3.2. Market Attractiveness Analysis
• 3.4. North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  • 3.4.1. Key Highlights
    • 3.4.1.1. U.S. Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
    • 3.4.1.2. U.S. Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
    • 3.4.1.3. U.S. Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
    • 3.4.1.4. Canada Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
    • 3.4.1.5. Canada Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
    • 3.4.1.6. Canada Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
  • 3.4.2. Market Attractiveness Analysis

4. Competitive Landscape

• 4.1. Company Market Share Analysis, 2022
• 4.2. Market Concentration by Top Players
• 4.3. Competitive Dashboard
• 4.4. Company Profiles
  • 4.4.1. Thermo Fisher Scientific
    • 4.4.1.1. Company Overview
    • 4.4.1.2. Product Portfolio
    • 4.4.1.3. Financial Overview
    • 4.4.1.4. Business Strategies and Development
  • 4.4.2. Bio-Rad Laboratories, Inc.
    • 4.4.2.1. Company Overview
    • 4.4.2.2. Product Portfolio
    • 4.4.2.3. Financial Overview
    • 4.4.2.4. Business Strategies and Development
  • 4.4.3. NEOGEN Corporation
    • 4.4.3.1. Company Overview
    • 4.4.3.2. Product Portfolio
    • 4.4.3.3. Financial Overview
    • 4.4.3.4. Business Strategies and Development
  • 4.4.4. Redwood Toxicology Laboratory, Inc.
    • 4.4.4.1. Company Overview
    • 4.4.4.2. Product Portfolio
    • 4.4.4.3. Financial Overview
    • 4.4.4.4. Business Strategies and Development
  • 4.4.5. Vala Sciences, Inc.
    • 4.4.5.1. Company Overview
    • 4.4.5.2. Product Portfolio
    • 4.4.5.3. Financial Overview
    • 4.4.5.4. Business Strategies and Development
  • 4.4.6. Enzo Life Sciences, Inc.
    • 4.4.6.1. Company Overview
    • 4.4.6.2. Product Portfolio
    • 4.4.6.3. Financial Overview
    • 4.4.6.4. Business Strategies and Development
  • 4.4.7. Alere, Inc.
    • 4.4.7.1. Company Overview
    • 4.4.7.2. Product Portfolio
    • 4.4.7.3. Financial Overview
    • 4.4.7.4. Business Strategies and Development
  • 4.4.8. Agilent Technologies, Inc.
    • 4.4.8.1. Company Overview
    • 4.4.8.2. Product Portfolio
    • 4.4.8.3. Financial Overview
    • 4.4.8.4. Business Strategies and Development
  • 4.4.9. Immunalysis Corporation
    • 4.4.9.1. Company Overview
    • 4.4.9.2. Product Portfolio
    • 4.4.9.3. Financial Overview
    • 4.4.9.4. Business Strategies and Development
  • 4.4.10. Danaher Corporation
    • 4.4.10.1. Company Overview
    • 4.4.10.2. Product Portfolio
    • 4.4.10.3. Financial Overview
    • 4.4.10.4. Business Strategies and Development
  • 4.4.11. Principle Diagnostics Laboratory
    • 4.4.11.1. Company Overview
    • 4.4.11.2. Product Portfolio
    • 4.4.11.3. Financial Overview
    • 4.4.11.4. Business Strategies and Development
  • 4.4.12. Principle Laboratory
    • 4.4.12.1. Company Overview
    • 4.4.12.2. Product Portfolio
    • 4.4.12.3. Financial Overview
    • 4.4.12.4. Business Strategies and Development
  • 4.4.13. Principle Diagnostics Laboratory
    • 4.4.13.1. Company Overview
    • 4.4.13.2. Product Portfolio
    • 4.4.13.3. Financial Overview
    • 4.4.13.4. Business Strategies and Development
  • 4.4.14. Clinical Reference Laboratory, Inc.
    • 4.4.14.1. Company Overview
    • 4.4.14.2. Product Portfolio
    • 4.4.14.3. Financial Overview
    • 4.4.14.4. Business Strategies and Development
  • 4.4.15. Medical Toxicology Laboratory, LLC
    • 4.4.15.1. Company Overview
    • 4.4.15.2. Product Portfolio
    • 4.4.15.3. Financial Overview
    • 4.4.15.4. Business Strategies and Development
  • 4.4.16. NMS Labs
    • 4.4.16.1. Company Overview
    • 4.4.16.2. Product Portfolio
    • 4.4.16.3. Financial Overview
    • 4.4.16.4. Business Strategies and Development
  • 4.4.17. BATTS Laboratories
    • 4.4.17.1. Company Overview
    • 4.4.17.2. Product Portfolio
    • 4.4.17.3. Financial Overview
    • 4.4.17.4. Business Strategies and Development
  • 4.4.18. Total Toxicology
    • 4.4.18.1. Company Overview
    • 4.4.18.2. Product Portfolio
    • 4.4.18.3. Financial Overview
    • 4.4.18.4. Business Strategies and Development
  • 4.4.19. Life Brite Labs.
    • 4.4.19.1. Company Overview
    • 4.4.19.2. Product Portfolio
    • 4.4.19.3. Financial Overview
    • 4.4.19.4. Business Strategies and Development
  • 4.4.20. Product Safety Labs
    • 4.4.20.1. Company Overview
    • 4.4.20.2. Product Portfolio
    • 4.4.20.3. Financial Overview
    • 4.4.20.4. Business Strategies and Development
  • 4.4.21. Lexar Labs
    • 4.4.21.1. Company Overview
    • 4.4.21.2. Product Portfolio
    • 4.4.21.3. Financial Overview
    • 4.4.21.4. Business Strategies and Development

5. Appendix

• 5.1. Research Methodology
• 5.2. Report Assumptions
• 5.3. Acronyms and Abbreviations